25,14% | % de acciones controlado por personas con información privilegiada |
87,12% | % de acciones controlado por instituciones |
116,39% | % de capital flotante controlado por instituciones |
161 | Número de participaciones de instituciones |
Accionista | Acciones | Fecha de notificación | % fuera | Valor |
---|---|---|---|---|
FMR, LLC | 5.355.867 | 30 mar 2024 | 14,90% | 27.904.067 |
State Street Corporation | 4.485.615 | 30 mar 2024 | 12,48% | 23.370.054 |
Cormorant Asset Management, LP | 3.570.872 | 30 mar 2024 | 9,93% | 18.604.243 |
Laurion Capital Management, LP | 2.720.983 | 30 mar 2024 | 7,57% | 14.176.321 |
Baker Brothers Advisors, LLC | 2.108.949 | 30 mar 2024 | 5,87% | 10.987.624 |
Blackrock Inc. | 1.973.500 | 30 mar 2024 | 5,49% | 10.281.935 |
Vanguard Group Inc | 1.365.625 | 30 mar 2024 | 3,80% | 7.114.906 |
Janus Henderson Group PLC | 1.285.278 | 30 mar 2024 | 3,58% | 6.696.298 |
Driehaus Capital Management, LLC | 1.193.953 | 30 mar 2024 | 3,32% | 6.220.495 |
Aisling Capital Management LP | 798.757 | 30 mar 2024 | 2,22% | 4.161.524 |
Accionista | Acciones | Fecha de notificación | % fuera | Valor |
---|---|---|---|---|
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 3.713.892 | 29 abr 2024 | 10,33% | 19.349.377 |
Fidelity Growth Company Fund | 1.621.171 | 29 abr 2024 | 4,51% | 8.446.300 |
Vanguard Total Stock Market Index Fund | 746.264 | 30 mar 2024 | 2,08% | 3.888.035 |
Fidelity Growth Company K6 Fund | 646.583 | 29 abr 2024 | 1,80% | 3.368.697 |
Fidelity Series Growth Company Fund | 518.127 | 29 abr 2024 | 1,44% | 2.699.441 |
Janus Henderson Global Life Sciences Fund | 518.637 | 30 mar 2024 | 1,44% | 2.702.098 |
iShares Russell 2000 ETF | 458.182 | 29 abr 2024 | 1,27% | 2.387.128 |
Fidelity Select Portfolios - Biotechnology | 392.829 | 29 abr 2024 | 1,09% | 2.046.639 |
Direxion Shares ETF Tr-Direxion Daily S&P Biotech Bull 3x Sh | 388.867 | 30 may 2024 | 1,08% | 2.025.997 |
Vanguard Extended Market Index Fund | 356.387 | 30 mar 2024 | 0,99% | 1.856.776 |